Abstract
Natalizumab-associated progressive multifocal leukoencephalopathy in multiple sclerosis (MS) occurred in two individuals also treated with interferon β1a, raising concerns about the interaction of these disease-modifying agents and leading to the recommendation to avoid their concomitant administration. However, type I interferons are antiviral. Using a real-time quantitative polymerase chain reaction for the detection and quantification of the John Cunningham virus (JCV), DNA in peripheral blood mononuclear cells (PBMCs), and urine in MS patients, we tested the hypothesis that MS disease-modifying drugs (DMD) qualitatively and quantitatively alter JCV prevalence and viral copy numbers. Two hundred thirty-nine patients were enrolled in a cross-sectional study in which blood and urine specimens were collected at a single time and 37 newly diagnosed, treatment-naïve MS patients were enrolled in a longitudinal study in which specimens were obtained at diagnosis and 6 months after treatment initiation. JCV DNA was detected in PBMCs of only two patients (0.07 %), but was commonly detected in the urine (46.8 %) in this population. There was no effect of DMDs on blood or urinary JCV prevalence or viral copy numbers with either glatira...Continue Reading
References
Aug 25, 1999·Current Opinion in Microbiology·C A Biron
Oct 29, 2002·Journal of Neurovirology·Han ChangDeching Chang
Jul 3, 2003·Journal of the National Cancer Institute·Jane MacKenzieRuth F Jarrett
Sep 18, 2003·Journal of Neurovirology·Elisabetta PaganiPasquale Ferrante
Jun 25, 2004·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·C PoloA Tenorio
Jun 11, 2005·The New England Journal of Medicine·Annette Langer-GouldDaniel Pelletier
Jun 11, 2005·The New England Journal of Medicine·B K Kleinschmidt-DeMasters, Kenneth L Tyler
Nov 22, 2005·Virology·Saguna VermaVivek R Nerurkar
Jan 13, 2006·Neurology·A NathE O Major
Jan 21, 2006·Nature Immunology·Taro Kawai, Shizuo Akira
Mar 3, 2006·The New England Journal of Medicine·Tarek A YousryDavid B Clifford
Jun 8, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Joseph R BergerHua Zhu
Jan 26, 2007·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·R Alvarez-LafuenteR Arroyo
Apr 25, 2007·Journal of Neurovirology·Serena DelbuePasquale Ferrante
Aug 4, 2007·The Journal of Infectious Diseases·Juliene K G CoVivek R Nerurkar
May 13, 2009·The Journal of Infectious Diseases·Adrian EgliHans H Hirsch
Aug 26, 2010·Annals of Neurology·Leonid GorelikMeena Subramanyam
Citations
Mar 4, 2014·ISRN Neurology·S LamdhadeR Alroughani
Nov 26, 2015·Therapeutic Advances in Neurological Disorders·Dejan PavlovicUNKNOWN Progressive Multifocal Leukeoncephalopathy Consortium
Sep 16, 2017·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Eric M L Williamson, Joseph R Berger
May 18, 2020·Neurology. Neuroimmunology and Neuroinflammation·Joseph R BergerAmit Bar-Or